Spots Global Cancer Trial Database for lymphomatoid papulosis
Every month we try and update this database with for lymphomatoid papulosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL | NCT03602157 | Lymphoma Immune System D... Immunoprolifera... Lymphatic Disea... Lymphoprolifera... Neoplasms Cutaneous Lymph... Cutaneous Anapl... Mycosis Fungoid... Sezary Syndrome Lymphomatoid Pa... Cutaneous T Cel... Gray Zone Lymph... | ATLCAR.CD30.CCR... ALTCAR.CD30 cel... Bendamustine Fludarabine | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients | NCT03587844 | Mycosis Fungoid... Lymphomatoid Pa... Sezary Syndrome | brentuximab ved... brentuximab ved... brentuximab ved... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma | NCT03409432 | Lymphomatoid Pa... Primary Cutaneo... Recurrent Prima... Recurrent T-Cel... Refractory Prim... Stage I Cutaneo... Stage II Cutane... Stage III Cutan... Stage IV Cutane... | Brentuximab Ved... Laboratory Biom... Lenalidomide | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. | NCT05106192 | Mycosis Fungoid... Cutaneous T-cel... Non Hodgkin Lym... Lymphomatoid Pa... Lymphoma, Large... Lymphoma, Folli... | Med-Jet Injecto... Triamcinolone A... Bexarotene 1% T... Nitrogen Mustar... Conventional sy... | 18 Years - | Case Comprehensive Cancer Center | |
| Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients | NCT03587844 | Mycosis Fungoid... Lymphomatoid Pa... Sezary Syndrome | brentuximab ved... brentuximab ved... brentuximab ved... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Tissue Repository: CTCL Collection Protocol | NCT02840747 | Lymphoma, T-Cel... Lymphomatoid Pa... Sézary Syndrom... | 18 Years - | Columbia University | ||
| SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) | NCT01352520 | CD-30 Positive ... Lymphoma, Prima... Lymphomatoid Pa... Mycosis Fungoid... Skin Lymphoma Cutaneous Lymph... Lymphoma Hematologic Dis... | SGN-35 | 18 Years - | M.D. Anderson Cancer Center | |
| Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. | NCT05106192 | Mycosis Fungoid... Cutaneous T-cel... Non Hodgkin Lym... Lymphomatoid Pa... Lymphoma, Large... Lymphoma, Folli... | Med-Jet Injecto... Triamcinolone A... Bexarotene 1% T... Nitrogen Mustar... Conventional sy... | 18 Years - | Case Comprehensive Cancer Center | |
| Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis | NCT06207812 | Lymphomatoid Pa... Mycosis Fungoid... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
